Q1 Earnings Estimate for McKesson Issued By Leerink Partnrs

McKesson Co. (NYSE:MCK) – Equities researchers at Leerink Partnrs lifted their Q1 2026 earnings per share (EPS) estimates for McKesson in a note issued to investors on Friday, May 9th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $8.73 per share for the quarter, up from their prior estimate of $8.34. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson’s Q2 2026 earnings at $8.27 EPS, Q3 2026 earnings at $9.39 EPS and FY2028 earnings at $48.22 EPS.

Several other equities analysts have also commented on the stock. Cfra Research lowered shares of McKesson from a “moderate buy” rating to a “hold” rating in a report on Friday, April 4th. UBS Group boosted their target price on McKesson from $708.00 to $805.00 and gave the company a “buy” rating in a research report on Tuesday, April 29th. Bank of America raised their price target on McKesson from $755.00 to $800.00 and gave the stock a “buy” rating in a research report on Friday, May 9th. Wells Fargo & Company lifted their price objective on McKesson from $641.00 to $691.00 and gave the company an “equal weight” rating in a research note on Friday, March 14th. Finally, StockNews.com raised McKesson from a “buy” rating to a “strong-buy” rating in a research note on Tuesday. Three research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $686.69.

McKesson Price Performance

Shares of MCK stock opened at $687.93 on Monday. McKesson has a 1-year low of $464.42 and a 1-year high of $728.48. The firm has a market cap of $86.22 billion, a PE ratio of 31.50, a price-to-earnings-growth ratio of 1.29 and a beta of 0.53. The company has a 50-day moving average of $680.08 and a two-hundred day moving average of $623.42.

McKesson (NYSE:MCK) last released its quarterly earnings results on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, topping analysts’ consensus estimates of $9.83 by $0.29. The business had revenue of $90.82 billion during the quarter, compared to analysts’ expectations of $94 billion. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The company’s revenue was up 18.9% compared to the same quarter last year. During the same period in the prior year, the business posted $6.18 EPS.

Institutional Investors Weigh In On McKesson

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. T. Rowe Price Investment Management Inc. increased its position in shares of McKesson by 8.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,847,385 shares of the company’s stock worth $1,622,754,000 after purchasing an additional 222,496 shares in the last quarter. Geode Capital Management LLC grew its stake in McKesson by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 2,663,303 shares of the company’s stock worth $1,513,195,000 after buying an additional 10,015 shares during the last quarter. Franklin Resources Inc. grew its stake in McKesson by 4.6% during the 4th quarter. Franklin Resources Inc. now owns 2,620,948 shares of the company’s stock worth $1,493,704,000 after buying an additional 114,396 shares during the last quarter. GAMMA Investing LLC increased its position in McKesson by 75,632.7% during the first quarter. GAMMA Investing LLC now owns 2,393,152 shares of the company’s stock worth $1,610,567,000 after buying an additional 2,389,992 shares during the period. Finally, Norges Bank purchased a new stake in McKesson in the fourth quarter valued at approximately $1,200,361,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the firm’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the sale, the chief executive officer now owns 60,664 shares of the company’s stock, valued at approximately $36,276,465.36. This trade represents a 12.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.11% of the stock is owned by company insiders.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be issued a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of 0.41%. The ex-dividend date is Monday, June 2nd. McKesson’s dividend payout ratio (DPR) is presently 10.99%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.